ADTX
Price
$0.67
Change
-$0.05 (-6.94%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
1.3M
Intraday BUY SELL Signals
ALPS
Price
$0.94
Change
-$0.02 (-2.08%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
164.72M
Intraday BUY SELL Signals
Interact to see
Advertisement

ADTX vs ALPS

Header iconADTX vs ALPS Comparison
Open Charts ADTX vs ALPSBanner chart's image
Aditxt
Price$0.67
Change-$0.05 (-6.94%)
Volume$200
Capitalization1.3M
Alps Group
Price$0.94
Change-$0.02 (-2.08%)
Volume$3.88K
Capitalization164.72M
ADTX vs ALPS Comparison Chart in %
ADTX
Daily Signal:
Gain/Loss:
ALPS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ADTX vs. ALPS commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADTX is a Hold and ALPS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (ADTX: $0.72 vs. ALPS: $0.96)
Brand notoriety: ADTX and ALPS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADTX: 3% vs. ALPS: 95%
Market capitalization -- ADTX: $1.3M vs. ALPS: $164.72M
ADTX [@Biotechnology] is valued at $1.3M. ALPS’s [@Biotechnology] market capitalization is $164.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADTX’s FA Score shows that 1 FA rating(s) are green whileALPS’s FA Score has 1 green FA rating(s).

  • ADTX’s FA Score: 1 green, 4 red.
  • ALPS’s FA Score: 1 green, 4 red.
According to our system of comparison, ALPS is a better buy in the long-term than ADTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADTX’s TA Score shows that 4 TA indicator(s) are bullish while ALPS’s TA Score has 2 bullish TA indicator(s).

  • ADTX’s TA Score: 4 bullish, 3 bearish.
  • ALPS’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ADTX is a better buy in the short-term than ALPS.

Price Growth

ADTX (@Biotechnology) experienced а -25.58% price change this week, while ALPS (@Biotechnology) price change was -1.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALPS($165M) has a higher market cap than ADTX($1.3M). ALPS YTD gains are higher at: 10.881 vs. ADTX (-13.685).
ADTXALPSADTX / ALPS
Capitalization1.3M165M1%
EBITDA-40.39MN/A-
Gain YTD-13.68510.881-126%
P/E RatioN/AN/A-
Revenue5.95KN/A-
Total Cash163KN/A-
Total Debt5.67MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ADTXALPS
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
14%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
10%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
19%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
29%
Advances
ODDS (%)
Bullish Trend 15 days ago
74%
Bullish Trend 3 days ago
49%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
48%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
25%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ADTX
Daily Signal:
Gain/Loss:
ALPS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPRX9.071.19
+15.10%
Eupraxia Pharmaceuticals
HVIIU10.600.04
+0.38%
Hennessy Capital Investmnt Corp VII
SLDE17.060.03
+0.18%
Slide Insurance Holdings Inc
KZIA6.06-0.14
-2.26%
Kazia Therapeutics Limited
GMED87.45-2.25
-2.51%
Globus Medical

ADTX and

Correlation & Price change

A.I.dvisor tells us that ADTX and ORMP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADTX and ORMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADTX
1D Price
Change %
ADTX100%
-9.66%
ORMP - ADTX
32%
Poorly correlated
+0.29%
IVF - ADTX
31%
Poorly correlated
-6.45%
XTLB - ADTX
27%
Poorly correlated
+0.06%
ALPS - ADTX
26%
Poorly correlated
-2.09%
HOWL - ADTX
25%
Poorly correlated
-2.42%
More

ALPS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPS has been loosely correlated with APLS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPS jumps, then APLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPS
1D Price
Change %
ALPS100%
-2.09%
APLS - ALPS
48%
Loosely correlated
+2.15%
ADTX - ALPS
26%
Poorly correlated
-9.66%
VNDA - ALPS
25%
Poorly correlated
+4.01%
VERU - ALPS
24%
Poorly correlated
-0.39%
TCRX - ALPS
23%
Poorly correlated
-2.37%
More